Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma

Clinical trial NCT05665023 · UNKNOWN

Trial details

NCT number: NCT05665023
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mucinous Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2022-10-28
Primary completion: 2024-02-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.